Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Farrell

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Molecular Genetics and Metabolism|March 20, 2012
Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screeningBradford L Therrell, W Harry Hannon, Gary Hoffman, et al.
Annals of Neurology|November 27, 2014
Cystic fibrosis newborn screening: a model for neuromuscular disease screening?Michele A Scully, Philip M Farrell, Emma Ciafaloni, et al.
American Journal of Epidemiology|July 16, 2002
Delayed diagnosis of US females with cystic fibrosisHui-Chuan Lai, Michael R Kosorok, Anita Laxova, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 11, 2011
Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screeningMei W Baker, Molly Groose, Gary Hoffman, et al.
Pediatric Pulmonology|December 16, 2011
The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosisDon B Sanders, Zhanhai Li, Michael J Rock, et al.
The Journal of Pediatrics|August 31, 2006
Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysisScott D Grosse, Margaret Rosenfeld, Owen J Devine, et al.
Maternal and Child Health Journal|April 19, 2013
Wisconsin's Lifecourse Initiative for Healthy Families: application of the maternal and child health life course perspective through a regional funding initiativeCatherine A Frey, Philip M Farrell, Quinton D Cotton, et al.
Pediatric Pulmonology|October 14, 2022
Detection of disease-causing CFTR variants in state newborn screening programsMeghan E McGarry, Clement L Ren, Runyu Wu, et al.
Pediatrics|January 28, 2009
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogenMolly Kloosterboer, Gary Hoffman, Michael Rock, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 14, 2003
Assessing personal qualities in medical school admissionsMark A Albanese, Mikel H Snow, Susan E Skochelak, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Molecular Genetics and Metabolism|March 20, 2012
Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screeningBradford L Therrell, W Harry Hannon, Gary Hoffman, et al.
Annals of Neurology|November 27, 2014
Cystic fibrosis newborn screening: a model for neuromuscular disease screening?Michele A Scully, Philip M Farrell, Emma Ciafaloni, et al.
American Journal of Epidemiology|July 16, 2002
Delayed diagnosis of US females with cystic fibrosisHui-Chuan Lai, Michael R Kosorok, Anita Laxova, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 11, 2011
Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screeningMei W Baker, Molly Groose, Gary Hoffman, et al.
Pediatric Pulmonology|December 16, 2011
The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosisDon B Sanders, Zhanhai Li, Michael J Rock, et al.
The Journal of Pediatrics|August 31, 2006
Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysisScott D Grosse, Margaret Rosenfeld, Owen J Devine, et al.
Maternal and Child Health Journal|April 19, 2013
Wisconsin's Lifecourse Initiative for Healthy Families: application of the maternal and child health life course perspective through a regional funding initiativeCatherine A Frey, Philip M Farrell, Quinton D Cotton, et al.
Pediatric Pulmonology|October 14, 2022
Detection of disease-causing CFTR variants in state newborn screening programsMeghan E McGarry, Clement L Ren, Runyu Wu, et al.
Pediatrics|January 28, 2009
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogenMolly Kloosterboer, Gary Hoffman, Michael Rock, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 14, 2003
Assessing personal qualities in medical school admissionsMark A Albanese, Mikel H Snow, Susan E Skochelak, et al.
Pageof 14